Synthesis,Antidiabetic and Antitubercular Evaluation of Quinoline–pyrazolopyrimidine hybrids and Quinoline‐4‐Arylamines

Abstract

Abstract Two libraries of quinoline‐based hybrids 1‐(7‐chloroquinolin‐4‐yl)‐1 H ‐pyrazolo[3,4– d ]pyrimidin‐4‐amine and 7‐chloro‐ N ‐phenylquinolin‐4‐amine were synthesized and evaluated for their α‐glucosidase inhibitory and antioxidant properties. Compounds with 4‐methylpiperidine and para ‐trifluoromethoxy groups, respectively, showed the most promising α‐glucosidase inhibition activity with IC 50 =46.70 and 40.84 μM, compared to the reference inhibitor, acarbose (IC 50 =51.73 μM). Structure‐activity relationship analysis suggested that the cyclic secondary amine pendants and para ‐phenyl substituents account for the variable enzyme inhibition. Antioxidant profiling further revealed that compounds with an N ‐methylpiperazine and N ‐ethylpiperazine ring, respectively, have good DPPH scavenging abilities with IC 50 =0.18, 0.58 and 0.93 mM, as compared to ascorbic acid (IC 50 =0.05 mM), while the best DPPH scavenger is NO 2 ‐substituted compound (IC 50 =0.08 mM). Also, compound with N ‐(2‐hydroxyethyl)piperazine moiety emerged as the best NO radical scavenger with IC 50 =0.28 mM. Molecular docking studies showed that the present compounds are orthosteric inhibitors with their quinoline, pyrimidine, and 4‐amino units as crucial pharmacophores furnishing α‐glucosidase binding at the catalytic site. Taken together, these compounds exhibit dual potentials; i. e ., potent α‐glucosidase inhibitors and excellent free radical scavengers. Hence, they may serve as structural templates in the search for agents to manage Type 2 diabetes mellitus. Finally, in preliminary assays investigating the anti‐tubercular potential of these compounds, two pyrazolopyrimidine series compounds and a 7‐chloro‐ N ‐phenylquinolin‐4‐amine hybrid showed sub‐10 μM whole‐cell activities against Mycobacterium tuberculosis .

Topics & Concepts